The 'Undercovered' Dozen highlights 12 lesser-covered stocks, offering investment ideas and encouraging discussions on their potential and market outlook. Beyond Inc. is rated a Strong Buy by Oskar Goyvaerts due to its turnaround plan, new CEO, and cost cuts aiming for breakeven FCF by Q3 2025. BioCGT Investor discusses the potential of Editas Medicine and Intellia Therapeutics despite market pessimism, with strategic pipeline reprioritization and significant upside targets possible.
I reiterate my 'Strong Buy' rating on EHang Holdings Limited due to a 1208.22% QoQ revenue rebound and significant government support. Government support is crucial for the eVTOL sector, evidenced by EH's regulatory approvals and incentives reducing production costs. The Company's financials are robust, with Q3'24 sales hitting a record 63 units and a 347.8% revenue increase, despite a slight margin decrease.
EHang Holdings Limited (NASDAQ:EH ) Q3 2024 Earnings Conference Call November 18, 2024 8:00 AM ET Company Participants Anne Ji - Senior Director, Investor Relations Huazhi Hu - Founder, Chairman and Chief Executive Officer Zhao Wang - Chief Operating Officer Conor Yang - Chief Financial Officer Conference Call Participants Cindy Wang - Morgan Stanley Laura Lee - Deutsche Bank Gareth Zhao - Tianfeng securities Yiming Wang - China Renaissance Operator Good day, ladies and gentlemen. Thank you for standing by and welcome to the EHang's Third Quarter 2024 Earnings Conference Call.
Initiating coverage on EHang Holdings with a "Buy" rating due to growth potential and favorable industry trends, with a 24-month investment horizon. EHang's diversified product offerings and strategic partnerships position it well to capitalize on China's expanding low-altitude economy and global eVTOL market. Strong order backlog, robust revenue growth, and significant R&D investments support a bullish outlook despite potential risks and industry competition.
EHang (Nasdaq: EH), a global leader in Urban Air Mobility technology, has announced a significant achievement with the first successful flight of its pilotless eVTOL aircraft in Brazil. Brazil's National Civil Aviation Agency (ANAC) recently issued an Experimental Flight Authorization (CAVE) for EHang's EH216-S, allowing trial operations.
EHang's EH-216 aircraft saw a nine-fold increase in unit sales, and the Company reported 920% revenue growth in Q2 2024. EH's unique certified autonomous eVTOL faces minimal competition, with a growing order book and expanded manufacturing capacity in China. A mathematical model suggests a fair value share price of $30, driven by industry-standard operating costs and continued explosive revenue growth.
2Q results showed strong revenue growth, breaking even on a non-GAAP basis, with surging orders and positive guidance for 3Q. More market entrants in eVTOL are unlikely to have an impact on EHang in the near future. EHang's business is now more sustainable with a healthy balance sheet and a large order backlog.
The aerial vehicle specialist unveiled its second-quarter results before market open. It crushed analyst estimates for the period.
Price pullbacks are healthy for the stock market, happening at a 15% correction every other year on average. The recent market correction offers flying car stocks to watch an opportunity for the big future play.
Flying car stocks have been explosive. Look at Joby Aviation (NYSE: JOBY ), for example.
It's time to buy some of the best flying car stocks on the cheap. If all goes well, the market for flying car stocks could become a trillion-dollar opportunity according to JPMorgan.
EHang Holdings is now in execution mode, collecting large orders, expanding production, and ramping revenues. The Chinese government wants to push the eVTOL sector to take a leading role, bringing about strategic initiatives, strong subsidies, and introducing first infrastructure projects. Regional actors in China are already supporting EHang with activities such as building vertiports and placing large orders, indicating a promising future.